Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01982383 · ClinicalTrials.gov registry record · NA

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

A NA study, sponsored by George Washington University.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT01982383: Clinical Trial NA study, sponsored by George Washington University.

NCT01982383 is a NA study that was terminated before completion, run by George Washington University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01982383, a NA study, was terminated before completion, sponsored by George Washington University.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

Primary Outcome

Central Serous Choroidopathy is a disease that causes fluid to build up under the retina,the back part of the inner eye that sends sight information to the brain. The objective here is to apply 577nm of micropulse laser to see if CSC resolution occurs and measuring it through ocular coherence tomography (retinal imaging), vision score, and visual field testing for retinal sensitivity.

Interventions

  • OTHER No treatment
  • DEVICE Micropulse Laser Treatment

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2012-11
Est. Completion 2015-11
Phase NA
George Washington University

133 total trials

Why NCT01982383 stopped before completion

NCT01982383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which No treatment is the first listed.

NCT01982383 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01982383 about?

NCT01982383 is a clinical study titled "Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy". The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

What is the current status of trial NCT01982383?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-11. Estimated completion is 2015-11.

What interventions are being tested in trial NCT01982383?

The interventions under investigation include: No treatment (OTHER), Micropulse Laser Treatment (DEVICE).

Who is sponsoring clinical trial NCT01982383?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01982383's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01982383, the US trial registry maintained by the National Library of Medicine. NCT01982383 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.